Market Overview
The French patient monitoring market covers bedside and central-station monitors, wearable sensors, telehealth platforms, and remote patient monitoring (RPM) solutions used in hospitals, clinics, and patients' homes. It is currently estimated at around USD 2.51 billion in 2025, with consensus projections pointing to USD 3.6-3.7 billion by 2030. Independent forecasts place the compound annual growth rate in the 7.8%-8.0% range, reflecting steady rather than explosive expansion.
- •2025 market size: approximately USD 2.51 billion
- •Compound annual growth rate: 7.8%-8.0% (used here as ~7.94%)
- •No French government statistical agency publishes an explicit USD market size; figures rely on private sector estimates
Growth Drivers
Demographic pressure is a central driver: France has one of Europe's oldest populations, increasing demand for continuous monitoring of cardiovascular, respiratory, and metabolic conditions. Parallel investment by the French government in digital health infrastructure, along with expanded reimbursement pathways for tele-monitoring under the Assurance Maladie, is supporting adoption across both hospital and home settings. Rising clinician familiarity with connected devices and post-COVID momentum behind virtual care models are reinforcing these structural tailwinds.
- •Aging population and growing prevalence of chronic disease increase demand for continuous monitoring
- •French national programs and reimbursement reforms are legitimizing remote and home-based monitoring
- •Clinician acceptance of connected devices accelerated during and after the COVID-19 period
Segmentation and Regional Analysis
The market is typically segmented by product (multi-parameter monitors, telemetry, wearables, and RPM platforms), acuity level (critical, general, and ambulatory/home care), and end user (hospitals, ambulatory centers, and home settings). Remote patient monitoring is the fastest-growing slice, with several analysts projecting double-digit CAGRs of roughly 13%-20% for the RPM sub-segment through the early 2030s. Geographically, demand is concentrated in the Île-de-France, Auvergne-Rhône-Alpes, and Provence-Alpes-Côte d'Azur regions, where major university hospitals and private clinic networks are based.
- •Remote patient monitoring is the fastest-growing sub-segment, with CAGRs reported between 13% and 20%
- •Multi-parameter bedside monitors remain the largest revenue contributor within hospitals
- •Demand is concentrated in densely populated regions with large teaching hospitals and private clinic groups
Trends and Outlook
What are the recent trends and outlook?
The outlook through 2030 points to continued mid-to-high single-digit growth in the overall market, with remote patient monitoring and AI-enabled analytics expanding faster than legacy bedside segments. Integration of monitoring data with the French electronic health record ecosystem, including shared record initiatives, is expected to deepen, while reimbursement clarity under ETAPES and its successor programs will shape adoption pace. Overall, France is positioned as one of Western Europe's more attractive patient monitoring markets, supported by public funding, demographic need, and an active supplier base.
- •Remote patient monitoring and AI-driven analytics are the principal sources of incremental growth
- •Reimbursement frameworks for tele-monitoring will remain a key determinant of adoption speed
- •France is expected to remain among the larger Western European patient monitoring markets through 2030
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.